To be better leaders, the administration should engage its primary audience: the faculty. Graphic by Miguel Tovar/University of Houston

The world of academic research is tough. As institutional research offices juggle regulatory and financial challenges within a continually strained system, they still have to lead their respective enterprises and serve their research communities.

“Service before leadership,” said Amr Elnashai, vice president/vice chancellor for research and technology transfer at the University of Houston. “We cannot miss this very important fact – we have to serve the needs of our research communities, first, before they will trust us to lead.”

How can we better serve faculty while tackling the many challenges faced by research divisions?

Sara Bible, associate vice provost for research at Stanford University, says the best way is to continually engage faculty in the business of research.

Rule making within research

Let’s be honest – faculty don’t particularly enjoy the administrative overburden dished out by university research offices. Nor should they.

But involving faculty in the process is the quickest way to earn their cooperation.

“You will have good results if you put in the time,” said Bible. “It’s really important to be flexible with faculty and staff on campus.”

One way Bible has successfully engaged her research community is in policy development. Her office at Stanford implemented a research policy working group that spends months testing policy language and effectiveness with university faculty and staff before it is launched.

“We’ve had great results,” she said. “People want to engage and be part of the process, not just be expected to follow a rigid set of rules.”

The pre-deadline deadline

Another way to partner with faculty is to work with them to improve the proposal review cycle, for everyone knows the risks of pushing the magic button mere minutes before the deadline.

Melinda Cotton, assistant vice president for Sponsored Programs at the University of Alabama at Birmingham, recommends creating a pre-deadline deadline.

Her office worked with faculty, schools and departments to establish the submission of proposals a full seven days before their due dates. This gave the office time to strengthen merit of the research project and fix minor details that could disqualify a proposal.

“Within our School of Medicine, more than 80 percent of our proposals came in by our pre-deadline,” she said. “We work hard to communicate and advocate to faculty that we can serve them better by doing it this way, and it’s working for us.”

Ultimately, there are lots of processes university research offices have to put in place to do the business of research. But to be better leaders, the administration should engage its primary audience: the faculty.

Engagement in policy-making, for instance, gives insight into pain points and allows research offices to put the best processes in place to get the job done for everyone.

------

This article originally appeared on the University of Houston's The Big Idea. Lindsay Lewis, the author of this piece, formerly served as the executive director of communications for the UH Division of Research.


Faculty in academia shouldn't be hesitant to follow their entrepreneurial goals just because it may be difficult to balance the two worlds. Graphic by Miguel Tovar/University of Houston

University of Houston: Tips for balancing faculty and founder life

Houston voices

Finding balance in your professional life and your dreams can be hard for anyone. Faculty in academia, hoping to become entrepreneur and start their own companies, find this especially difficult. Finding this balance is essential to having success both professionally and in entrepreneurial endeavors.

Amy J. Ko, a professor at the University of Washington Information School and Co-Founder of AnswerDash, said in a post on her Bits and Behavior blog that she found parallels between being an entrepreneur and being a professor that helped her start her technology company.

Here are four parallels between startup life and faculty life that Ko found striking.

1. Fundraising.

"I spend a significant amount of my time seeking funding, carefully articulating problems with the status quo and how my ideas will solve these problems. The surface features of the work are different—in business, we pitch these ideas in slide decks, elevators, whereas in academia, we pitch them as NSF proposals and DARPA white papers—but the essence of the work is the same: it requires understanding the nature of a problem well enough that you can persuade someone to provide you resources to understand it more deeply and ultimately address it."

2. Experimentation.

"Research requires a high degree of iteration and experimentation, driven by carefully formed hypotheses. Startups are no different. We are constantly generating hypotheses about our customers, our end users, our business plan, our value, and our technology, and conducting experiments to verify whether the choice we've made is a positive or negative one."

3. Learning.

"Both academia and startups require a high degree of learning. As a professor, I'm constantly reading and learning about new discoveries and new technologies that will change the way I do my own research. As a founder, and particularly as a CTO, I find myself engaging in the same degree of constant learning, in an effort to perfect our product and our understanding of the value it provides."

4. Teaching.

"The teaching I do as a CTO is comparable to the teaching I do as a Ph.D. advisor in that the skills I'm teaching are less about specific technologies or processes, and more about ways of thinking about and approaching problems."

Ko also mentions the distinct differences between the two are the pace, the outcomes, and the consequences.

Finding Balance as a Professor and Entrepreneur

Alaina G. Levine, an award-winning entrepreneur, science journalist, and STEM careers consultant said in a Science Mag blog post that the key to success is to find ways to balance the two worlds.

"Issues of intellectual property ownership, human resources protocols, and time management, as well as the challenge of keeping a delineated barrier between professorial and business activities can be difficult to manage, but these concerns shouldn't prevent academics from seeking to create a startup company," Levine said in the blog post.

How to Balance Entrepreneurship and Faculty Responsibilities

According to Levine, these are a few things to consider before perusing entrepreneurship in order to successfully balance professorial and entrepreneurial activities:

1. Know your priorities

"If you are a professor who ponders whether your research can be developed into a technology that can be commercialized, your initial step should be to ponder your priorities. Do you want to stay in academia? Do you desire a career in industry? Deciding these choices early on, even before the lawyers and university representatives get involved, is crucial to forging a balance and a satisfying career."

2. Figuring out what path to take

"To wrangle the options and make it through the multiverse of marketing and manufacturing without sacrificing professorial duties, an academic's initial stop should be their institution's office of technology transfer (OTT). The OTT can assist faculty with understanding how much time they can spend on outside endeavors and how it must be structured. Technology transfer professionals also provide insight into patent law and can help professors navigate intellectual property (IP) issues."

3. Managing potential conflicts of interest

"Once you engage in entrepreneurship, you must create a distinct separation between your university lab and your company's facilities. IP can't flow freely between the two, and neither can labor—your grad students cannot work for you in your group and intern at your company at the same time. Safeguards that prevent mingling are necessary for legal purposes, say experts, as well as to synthesize a balance between being in academia and being in business."

4. Getting a Return on Investment on the faculty side

"Even with a targeted separation of academic and business endeavors, pursuing commercialization can actually enhance your skills in education. The connections that faculty make not only help the students but benefit the department and university as a whole as well."

What's The Big Idea?

Faculty in academia shouldn't be hesitant to follow their entrepreneurial goals just because it may be difficult to balance the two worlds. Take what you already know as a professor and apply it to your new venture as an entrepreneur. Also, know where your priorities lie, what path you're taking, watch out for conflicts of interest and make sure you, your students and university are all getting something out of it.

According to both writers, universities and research go hand in hand and both are "of critical importance" to the advancement of our society. So, is your research impactful? If the answer is yes, go for it.

------

This article originally appeared on the University of Houston's The Big Idea. Cory Thaxton is the communications coordinator for The Division of Research.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

3 Houston incubators and accelerators fueling the growth of local startups

Meet the finalists

It takes a village to launch a business. That's where Houston's network of incubators and accelerators can step in, providing the resources, mentorship and community needed to push a fledgling company forward.

As part of our 2026 Houston Innovation Awards, the Incubator/Accelerator of the Year category honors a local organization that is championing and fueling the growth of Houston startups.

Three incubators and accelerators have been named finalists for the 2026 award. They support startups ranging from hard-tech companies to food and youth concepts.

Read more about these organizations below. The 2026 winners will be announced on InnovationMap.com in mid-November.

Activate

Hard tech incubator Activate supports scientists in "the outset of their entrepreneurial journey." The Houston hub was introduced in 2024, and joins others in Boston, New York, and Berkley, California—where Activate is headquartered. It named its third Houston cohort this summer.

The two-year program graduated its first class of Houston fellows in 2026 and saw its first alumni IPO from Houston-based Fervo Energy, which previously participated in a Berkley cohort. Nationally, it has supported 346 fellows and 276 companies since 2015. Those companies have raised more than $6 billion in follow-on funding, according to Activate. In Houston, it has supported Houston startups like Solidec, FlowCellutions and Orbital Arc. Activate Houston is led by managing director Jeremy Pitts, who co-founded Greentown Labs in Boston. It is based out of the Ion.

Impact Hub Houston

Impact Hub Houston supports early-stage ventures at various stages of development through innovative programs that address pressing societal issues. The nonprofit organization supports social impact startups through mentorship, connections and training opportunities.

There are more than 110 Impact Hubs globally with members spanning 72 countries. Launched in 2018, Impact Hub Houston says its membership tripled by the beginning of 2026. This year brought major milestones for the community, including the launch of its Ideas to Impact Accelerator, which supported 11 founders across the health, education, food systems, civic technology and workforce development sectors. It also received funding from more than 20 international Impact Hubs to develop SYNC, a collaboration platform that 25 Impact Hubs across five continents have committed to pilot. The organization has worked with local startups including Myoviva Health, The Change Lab and INNERVERSE Inc.

MarMo Innovation

Galveston-based business incubator MarMo Innovation is focused on removing barriers to entrepreneurship. It aims to provide affordable space, education, mentorship, market access, connections and real-world opportunities that help entrepreneurs move from idea to launch to sustainable growth. The "industry-agnostic" incubator was founded in 2022 and is led by Executive Director Erica Delgadillo.

This year, the organization moved from primarily serving as a coworking and community space into a more comprehensive entrepreneurial incubator by expanding its MarMo Market, MarMo Market Jr. and Lunch LineUp programs. A major focus for MarMo is food entrepreneurship. It is developing an Incubator Kitchen, which MarMo says will support programs like its Cottage to Commercial Bootcamp and Food Biz 101. The organization also expanded its board this year and says it is diversifying its revenue through memberships, events, markets, equipment and space rentals, sponsorships, grants and new entrepreneurial programming.

Baylor College of Medicine launches VC fund to invest in biotech startups

fresh funding

Houston’s Baylor College of Medicine just unveiled a new venture capital fund that backs early-stage biotech startups—and it’s already made its first investment.

BCM Legacy Fund I, funded by philanthropies, invested an undisclosed amount in Houston biotech startup Nemea Therapeutics. Nemea, a spinout of the Baylor College of Medicine and Germany’s Lead Discovery Center, is developing an oral drug to treat metastatic triple-negative breast cancer that no longer responds to currently available therapies.

This type of aggressive cancer spreads from the breast to other areas of the body, such as the bones, liver, lungs or brain. Roughly 38,000 to 57,000 Americans are diagnosed each year with metastatic triple-negative breast cancer. One study showed about half of patients survive past the one-year mark following diagnosis and about one-third survive two years.

“Baylor College of Medicine’s laboratories produce discoveries with the potential to change patients’ lives, and too many of them stall where academic funding ends and private investment has not yet begun,” Dr. Jakub Tolar, president, CEO and executive dean of the Baylor College of Medicine, said in a press release. “The BCM Legacy Fund fills that gap, giving our scientists a path to advance their discoveries to patients.”

The National Institutes of Health awards more than $36 billion per year for biomedical research in the U.S., Baylor said. But some biomedical discoveries “never leave the starting line because they don’t yet fit the economics of venture capital,” the college said.

“The forefront of a new model”

The BCM Legacy Fund aggregates philanthropic capital from private foundations and donor-advised funds. It then invests in startups so they can move beyond that starting line and into later-stage investment rounds. The Greater Houston Community Foundation is the fund’s philanthropic partner.

“It’s exciting to be on the forefront of a new model for philanthropic capital,” said Houston entrepreneur and investor Burton Hanson, managing partner of the fund.

“Not only do we hope to solve a real problem by advancing these therapies to the patients who need them most, but we also hope this model will inspire others in the city and beyond toward philanthropic creativity and a posture of ‘I sacrifice; we win.’”

The fund expects to invest in about 15 early-stage startups over a five-year span. Baylor declined to divulge the amount of money in the fund and the size of the investment in Nemea.

Nemea’s “world-class chemistry”

Hanson oversees the Baylor fund alongside Chicago investor Steve Lehmann, who led the University of Chicago’s Innovation Fund.

Lehmann said Nemea, the fund’s first portfolio company, “has world-class chemistry, Baylor biology, and patients with no good options. Our job is to fund the experiments that carry it to the next handoff, so that industry and later-stage investors can take it from there.”

Based at Houston’s massive Texas Medical Center, Nemea plans to start clinical trials next year in collaboration with Baylor’s Lester and Sue Smith Breast Center.

Nemea previously received $9 million from the Lead Discovery Center and a $1.6 million grant from Baylor. Last year, the startup said it was seeking $25 million to $30 million in seed and Series A funding.

Debra McCoy of Houston, a former managing director at BlackRock and former partner at Bain & Co., and Paul Thomas, co-founder and CEO of Spring-based benefits manager Luscinia Health, sit on the Baylor fund’s governing board. Dr. Paul Klotman, former president, CEO and executive dean of Baylor, is a senior strategic adviser.

How does the fund find investment targets?

The Baylor Legacy Fund relies on two tools to help unearth early-stage biotech startups:

  • High-resolution “innovation maps” of research institutions. These maps surface hidden clusters of innovation, identify rising-star researchers and tie pockets of “innovation supply” at Baylor to areas of “innovation demand” in biotech.
  • AI-enhanced due diligence. AI agents assist with due diligence of early-stage biotech startups. The fund says the platform “distills the frameworks we’ve developed over a decade of teaching and investing into a flexible … diligence environment.”

MD Anderson unveils $3.4B expansion with two new Houston cancer care facilities

major expansion

The cutting edge of cancer-fighting technology and science is getting even sharper after MD Anderson announced last week that it will open two new facilities in the Texas Medical Center within the next five years. Inspiration Tower and Prism will expand MD Anderson’s annual patient load in the TMC to 250,000 annually and will incorporate a variety of new techniques.

The $3.4 billion project will add 2 million square feet to MD Anderson's TMC footprint, bringing its total campus size to 22 million square feet by 2032. Located at the corner of Fannin Street and Holcombe Boulevard, the cancer center says the two new facilities will serve as its new "front door" to the TMC.

“Every detail of these buildings, from the technology to the treatment rooms, was designed around our patients who will receive their care in them and our employees who will work in them. The facilities will serve as a physical representation of hope for the patients and their families who will walk through the doors,” Dr. Jeffrey E. Lee, president ad interim of UT MD Anderson, said in a news release. “Inspiration Tower and Prism are the future of cancer care, and we are grateful for the longstanding support and guidance we’ve received from the UT System Board of Regents to bring these projects to life. These facilities are part of the most impactful capital expansion in UT MD Anderson’s history.”

Prism is especially exciting as it will represent fully half of the linear accelerator treatment in the TMC. Linear accelerator is a radiation treatment that uses magnetically charged fields to deliver targeted external radiation therapy, like shooting cancer with a rail gun. The treatment is safer and has fewer side effects than older radiation treatments.

In addition, Prism will contain 12 MRI machines, four CT scanners, two PET-CT units, 18 radiation vaults and seven radiation simulators. Patient comfort has also been put at a premium with multiple gardens and roof overlooks.

“Every patient we treat deserves an environment that reflects the excellence of the care they receive at UT MD Anderson,” Chris McKee, executive vice president and chief strategy officer at UT MD Anderson, added in the release. “Our new facilities will be innovative, agile, adaptable and beautiful, and they will allow us to care for more patients, more effectively – in an environment that enhances healing and well-being. We are building for our future and for every patient who will be counting on us.”

Prism is slated to open in 2030.

Inspiration Tower will have 25 floors of surgical, diagnostic, and treatment services. At 1.4 million square feet, it’s currently expected to be the largest cancer-specific treatment facility in the United States. The tower will be divided into units for specific types of cancer, making it easy to integrate the advancing research being done all over Houston.

Like Prism, Inspiration Tower is specifically designed to offer comfort and reassurance, with more garden space, terraces, and beautiful scenery to ease patient distress. It is expected to open in 2032.